420
Views
31
CrossRef citations to date
0
Altmetric
Original Research

Anticancer efficacy enhancement and attenuation of side effects of doxorubicin with titanium dioxide nanoparticles

, , , &
Pages 2321-2326 | Published online: 18 Oct 2011

References

  • ZhengJLeeHCMbin SattarMMHuangYBianJSCardioprotective effects of epigallocatechin-3-gallate against doxorubicin-induced cardiomyocyte injuryEur J Pharmacol2011562828821114975
  • IbsenSZahavyEWrasdiloWBernsMChanMEsenerSA novel doxorubicin prodrug with controllable photolysis activation for cancer chemotherapyPharm Res2010271848186020596761
  • YousefpourPAtyabiFFarahaniEVSakhtianchiRDinarvandRPolyanionic carbohydrate doxorubicin-dextran nanocomplex as a delivery system for anticancer drugs: in vitro analysis and evaluationsInt J Nanomedicine201161487149621796249
  • JeongYIKimDHChungCWDoxorubicin-incorporated polymeric micelles composed of dextran-b-poly(DL-lactide-co- glycolide) copolymerInt J Nanomedicine201161415142721796244
  • LiCWallaceSPolymer-drug conjugates: recent development in clinical oncologyAdv Drug Deliv Rev20086088689818374448
  • JannesariMVarshosazJMorshedMZamaniMComposite poly(vinyl alcohol)/poly(vinyl acetate) electrospun nanofibrous mats as a novel wound dressing matrix for controlled release of drugsInt J Nanomedicine20116993100321720511
  • ChenBAMaoPPChengJReversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and MDR1 shRNA expression vector in leukemia cellsInt J Nanomedicine2010543744420957165
  • WuWWChenBAChengJBiocompatibility of Fe3O4/DNR magnetic nanoparticles in the treatment of hematologic malignanciesInt J Nanomedicine201051079108421170355
  • WangJChenBAChengJApoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co- loaded with daunorubicin and 5-bromotetrandrinInt J Nanomedicine201161027103421720514
  • WangJChenBAChengJSynthesis and antitumor efficacy of daunorubicin-loaded magnetic nanoparticlesInt J Nanomedicine2011620321121445276
  • ZhangHJChenBAJiangHWangCLWangHPWangXMA strategy for ZnO nanorod mediated multi-mode cancer treatmentBiomaterials2011321906191421145104
  • BarickKCNigamSBahadurDNanoscale assembly of mesoporous ZnO: A potential drug carrierJ Mater Chem20102064466452
  • SongMZhangRYDaiYYThe in vitro inhibition of multidrug resistance by combined nanoparticulate titanium dioxide and UV irradiationBiomaterials2006274230423816600364
  • LiQNWangXMLuXHThe incorporation of daunorubicin in cancer cells through the use of titanium dioxide whiskersBiomaterials2009304708471519500830
  • ZhangHJJiangHWangHPZhaoJChenBAWangXMUltrasound mediated drug-loaded nanoparticles crossing cell membranes as a new strategy to reverse cancer multidrug resistanceJ Nanosci Nanotechnol2011111834184021449318
  • ZhangDWZhangHNieJYangJSynthesis and self-assembly behavior of pH-responsive amphiphilic copolymers containing ketal functional groupsPolym Int201059967974
  • YooHSLeeKHOhJEParkTGIn vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin-PLGA conjugatesJ Control Release20006841943110974396
  • Granados-PrincipalSQuilesJLRamirez-TortosaCLSanchez-RoviraPRamirez-TortosaMCNew advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrientsFood Chem Toxicol2010481425143820385199
  • YangEKorsmeyerSJMolecular thanatopsis: A discourse on the BCL2 family and cell deathBlood1996883864018695785
  • GhavamiSHashemiMAndeSRApoptosis and cancer: Mutations within caspase genesJ Med Genet20094649751019505876